Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2014, Vol. 19 ›› Issue (11): 1255-1258.

Previous Articles     Next Articles

Investigation of the rs28371759 polymorphism of CYP3A4 gene in Guangdong population

WANG Rong, CHEN Ke-rui, LIU Xiao-mei, TANG Hui-en, HE Zhen-yu   

  1. Department of Biochemistry and Molecular Biology,Guangdong Pharmaceutical University, Guangzhou 510006, Guangdong, China
  • Received:2013-07-22 Revised:2014-11-03 Online:2014-11-26 Published:2014-12-09

Abstract: AIM: To study the genotype distribution of rs28371759(20070T>C) polymorphism of CYP3A4 in Guangdong population and to supply reference information for clinical safe medication of drugs metabolized by CYP3A4. METHODS: Taking 200 Guangdong volunteers' buccal swabs DNA as templates, then the DNA fragments encompassing the rs28371759 polymorphic locus were amplified by polymerase chain reaction,the amplified products were subjected to restriction enzyme analysis with MspI, then the digested products were subjected to polyacrylamide gel electrophoresis and sliver-staining, restriction enzyme maps derived were used for determining the corresponding genotypes.RESULTS: Among these detected 200 samples, heterozygotes were found in 3 cases, while the others were wild-types. The wild homozygotes, heterozygotes, mutant homozygotes were 0.985, 0.015, 0 respectively. The frequency of mutant allele 20070C was 0.0075.CONCLUSION: This research shows distribution of CYP3A4 gene rs28371759 polymorphism locus in Guangdong population, which lay a foundation for researching the relationship between CYP3A4 gene polymorphism and clinical drug effect.

Key words: Guangdong population, CYP3A4*18A, polymorphism

CLC Number: